Table 3.
Phenotypical characterization of melanoma cell lines
| Cell line | CD133 | CD105 | CD146 | CD271 | CD117 |
|---|---|---|---|---|---|
|
MZ2 |
neg. |
86.41 |
73.92 |
99.74 |
neg. |
|
D10 |
89.66 |
77.14 |
98.79 |
neg. |
neg. |
|
Me39 |
1.88 |
95.65 |
100.00 |
7.40 |
neg. |
|
WM115 |
neg. |
87.60 |
99.6 |
45.24 |
neg. |
|
RE |
3.11 |
74.84 |
98.31 |
59.96 |
1.28 |
|
Me59 |
1.00 |
75.55 |
36.40 |
2.72 |
18.95 |
|
Me67 |
neg. |
75.94 |
73.76 |
10.75 |
neg. |
|
Na8 |
1.05 |
97.22 |
0.67 |
82.54 |
neg. |
| HBL | neg. | 22.66 | 30.08 | 2.32 | 99.46 |
Expression levels of fluorochrome-conjugated monoclonal antibodies against surface markers of interest on melanoma cell lines. Frequency and distribution of cells carrying surface markers expressed as percentages of positive gated cells; “neg.” indicates percentages of positive gated cells <1%.